Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 245 recruiting now early-phase tilt #5 of 28,963 conditions

Depression: early-phase trial registry

245 of 687 indexed Depression trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #5 of 28,963 conditions by registered trial count.

687 US clinical trials · 245 currently recruiting · #5 of 28,963 conditions by registered trial count

Depression: 687 US clinical trials tracked, 245 recruiting.

Depression is the subject of 687 registered US clinical trials on ClinicalTrials.gov, 245 of them currently open to new participants. 70 are in Phase 3-4 (later-stage) and 111 in Phase 1-2 (earlier-stage). The most active sponsor is Massachusetts General Hospital, running 29 of these trials.

Open enrollment, early-phase tilt

Depression has 687 registered US clinical trials, 245 of them open to new participants right now, about 36% of the total.

245
recruiting participants now
36%
of trials open to enrollment
70
in Phase 3-4 (later-stage)
29
top sponsor: Massachusetts General Hospital

Corpus placement: #5 of 28,963 conditions by registered trial count on ClinicalTrials.gov-derived indexes. Registry reference only, not medical advice.

Key findings

What ClinicalTrials.gov does not surface for Depression on its own pages , computed from the registry mirror as of 2026-07-11. Each line carries its own denominator so it can be quoted as it stands.

  1. Depression recruits in line with its size-band peers.

    245 of 687 indexed trials (35.7%) are open to enrollment, against a 37.2% average across 135 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Depression trials is spread across many organizations.

    Massachusetts General Hospital accounts for 29 of 687 trials (4.2%). 231 distinct sponsors appear on at least one study for this condition label.

  3. Typical Depression enrolment sits around 100 participants.

    Median target enrolment is 100 among the 680 trials that report a genuine target (sentinel values excluded). 331 of those (48.7%) plan for fewer than 100 participants.

  4. Depression research is mostly interventional.

    618 interventional and 69 observational studies make up this index (90% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 141Phase 270Phase 329Phase 441

Open and recent trials

687 total, page 14 of 14

COMPLETED NA 16 participants

Increasing Physical Activity Among Breast Cancer Survivors With Depression

University of Texas Southwestern Medical Center

NCT02781051

COMPLETED NA 16 participants

Effects of a Volunteer-based Lunch Program on Feelings of Loneliness in Elders

University of South Florida

NCT03552328

COMPLETED NA 16 participants

Brief Inpatient Psychotherapy for Depression

Cedars-Sinai Medical Center

NCT03091582

COMPLETED Phase 4 15 participants

Paroxetine/Bupropion in Depression With Suicide Attempt or Thoughts: fMRI Study

New York State Psychiatric Institute

NCT01748955

COMPLETED Phase 2 15 participants

Buprenorphine for Late-Life Treatment Resistant Depression

University of Pittsburgh

NCT01071538

COMPLETED Phase 4 15 participants

Wellbutrin XL Effects on SSRIs Induced Changes

Indiana University School of Medicine

NCT00456820

COMPLETED NA 13 participants

Treating Self Injurious Behavior: A Novel Brain Stimulation Approach

New York State Psychiatric Institute

NCT04244786

COMPLETED NA 13 participants

Meditation for Depression

University of California, San Francisco

NCT01671436

COMPLETED NA 13 participants

TMS for Adults With Autism and Depression

Medical University of South Carolina

NCT02939560

COMPLETED NA 12 participants

HOPE Pilot for Veterans With Complex Diabetes

Michael E. DeBakey VA Medical Center

NCT01274715

COMPLETED NA 12 participants

rTMS in Treatment Resistant Depression

Emory University

NCT02080507

COMPLETED NA 12 participants

Unilateral Massage as a Potential Treatment for Depression

University of Arizona

NCT01937897

COMPLETED NA 12 participants

Video-visit Behavior Therapy for Anxiety and Depression in Youth

San Diego State University

NCT05417412

COMPLETED Phase 2 12 participants

Ketamine for Depression and Suicide Risk

Mayo Clinic

NCT02094898

COMPLETED NA 10 participants

Affect Treatment for Depression and Anxiety (TAD Pilot)

University of California, Los Angeles

NCT06488859

COMPLETED NA 9 participants

Daily Weight Feedback for Wheelchair Users to Promote Weight Loss

Jonathan Pearlman

NCT03264248

COMPLETED Phase 2 9 participants

Cognitive Behavioral Therapy (CBT) for Adherence and Depression in Type 1 Diabetes

Massachusetts General Hospital

NCT01527981

COMPLETED NA 9 participants

Virtual Reality at End-of-life

State University of New York at Buffalo

NCT06149429

COMPLETED NA 8 participants

The Feasibility of Engage Therapy With Video Support for Homebound Older Adults

Weill Medical College of Cornell University

NCT05346055

COMPLETED NA 8 participants

An Evaluation of Safety and Feasibility Using Repetitive Transcranial Magnetic Stimulation (rTMS) in Adolescents With Depression

Mayo Clinic

NCT00587639

COMPLETED Phase 1 8 participants

Healthy Heart Habits

Hennepin Healthcare Research Institute

NCT04158219

COMPLETED NA 7 participants

Early Detection and Prevention of Mood Disorders in Children of Parents With Bipolar Disorder

New York State Psychiatric Institute

NCT00338806

COMPLETED NA 6 participants

Companion Dog Walking for ICU Survivor Health

University of Missouri, Kansas City

NCT05820308

COMPLETED NA 6 participants

Cranial Electrotherapy Stimulation (CES) Therapy

The University of Texas Health Science Center at San Antonio

NCT02453347

COMPLETED NA 5 participants

Venlafaxine for Depression in Alzheimer's Disease (DIADs-3)

Johns Hopkins University

NCT01609348

COMPLETED Phase 2 5 participants

Electrical Stimulation of the Internal Capsule for Intractable Depression

Butler Hospital

NCT01069952

COMPLETED Early Phase 1 4 participants

Study of Oral Ketamine Versus Placebo for Treating Depression in Patients Undergoing Treatment for Cancer

Scott A. Irwin, MD, PhD

NCT02836288

COMPLETED NA 2 participants

Cognitive Behavioral Therapy for Insomnia with RTMS

Medical University of South Carolina

NCT04258618

COMPLETED NA 1 participants

Feasibility of Egg-Based Diet Interventions and Assessing Perinatal Mental Health

University of Idaho

NCT05619445

COMPLETED NA 1 participants

Collaborative Care Intervention for Cancer Caregivers

University of Pittsburgh

NCT02944136

COMPLETED Phase 4

The Depression in Alzheimer's Disease Study (DIADS)

Johns Hopkins University

NCT00009191

COMPLETED NA

Gabapentin For the Control of Hot Flashes in Women With Breast Cancer

Gary Morrow

NCT00022074

COMPLETED Phase 2

Antidepressant Treatment of AIDS Related Depression.

GEIGY Pharmaceuticals

NCT00000390

COMPLETED Early Phase 1

Cytokine-Associated Depression and Social Pain

University of California, Los Angeles

NCT00949845

COMPLETED NA

Intervention to Decrease Anxiety in Parents of Infants in the Neonatal Intensive Care Unit (NICU)

Stanford University

NCT00186472

COMPLETED NA

Music Therapy to Ease Pain and Emotional Distress in Patients With Hematologic Cancer Who Are Undergoing High-Dose Therapy and Stem Cell Transplantation

Memorial Sloan Kettering Cancer Center

NCT00014482

COMPLETED

Major Depression and Inflammatory Risk Markers for Coronary Heart Disease

National Center for Research Resources (NCRR)

NCT00037505

← Previous Page 14 of 14

Phase Distribution

PhaseTrial count
Phase 1 41
Phase 2 70
Phase 3 29
Phase 4 41

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What is open for Depression right now

245 recruiting of 687 indexed (36% open).

Phase mix: 70 late (III/IV) vs 111 early (I/II) (early-phase heavy).

Top sponsor: Massachusetts General Hospital (29 trials), 9 others listed. 37 shown below, recruiting first. #5 of 28,963 conditions by registered trial count.

How open-enrollment share is computed

Open share is recruiting_count divided by trial_count for this condition label in the public registry export. Status can change between pulls; treat the figure as a snapshot of research attention, not treatment availability.

Frequently Asked Questions

How many clinical trials are there for Depression?

PlainTrial tracks 687 US clinical trials for Depression, of which 245 are currently recruiting participants. Data sourced from ClinicalTrials.gov.

How do I find a recruiting trial for Depression?

Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.

Is this data current?

Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.

Verify with NIH →

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial for this condition, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.